by Steven Grossman | Aug 11, 2025 | Uncategorized
Dear FDA Matters subscribers–—“Q&A Friday” is now “Q&A Monday,” a subscriber-first feature of FDA Matters. It is on the record, so subscribers (including reporters) can use and circulate the Q&A immediately upon receipt.Subscribers are encouraged to submit...
by Steven Grossman | Aug 8, 2025 | Short Takes and Updates
FDA Matters doesn’t cover the news….we provide analysis of what’s behind the newsThis week: August in DC—No Longer SlowThe Difficult Path to An FDA that Is “Just Right,” Neither Too Hard Nor Too Soft Former FDA Commissioner David Kessler...
by Steven Grossman | Aug 4, 2025 | Uncategorized
Dear FDA Matters subscribers–—“Q&A Friday” is now “Q&A Monday” so that I can thoughtfully answer questions based on the past week’s news. It is on the record, so subscribers (including reporters) can use and circulate the Q&A immediately upon...
by Steven Grossman | Jul 31, 2025 | Short Takes and Updates
Every day, we are failing patients with chronic progressive neurological, neuromuscular, and genetic diseases. The brouhaha about Sarepta and Elevidys[1][2] is just a reminder that we are not systematically addressing the common plight of these patients: 1/ their...
by Steven Grossman | Jul 25, 2025 | Short Takes and Updates
FDA Matters doesn’t cover the news….we provide analysis of what’s behind the newsThis week: Familiarity Breeds Respect Imminent Danger Regarding Food Priorities New CDER Leadership Re-Exploring Reconciliation Cuts’ Impact on FDA Consumer Protection...
